Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

4.450

-0.175 (-3.78%)

At close: Oct 10, 2025, 4:00 PM EDT

4.340

-0.110 (-2.47%)

After-hours: Oct 10, 2025, 6:37 PM EDT

Kalaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Oct '25 Oct 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Cap	83	-	-	-	-	-	Upgrade
Enterprise Value	-5.2	63.9	-167.3	-205.57	-224.65	-350.86	Upgrade
PB Ratio	1.57	0	0	0	0	0	Upgrade
EV/EBITDA Ratio	-	-0.98	0.87	1.22	1.33	4.93	Upgrade
EV/EBIT Ratio	-	-0.98	0.84	1.20	1.32	4.92	Upgrade
EV/FCF Ratio	-	-0.94	1.34	1.45	2.11	5.75	Upgrade
Debt / Equity Ratio	0	-0.39	0.11	0.13	0.10	0.02	Upgrade
Debt / EBITDA Ratio	-	-0.30	-0.14	-0.21	-0.18	-0.12	Upgrade
Debt / FCF Ratio	-	-0.29	-0.22	-0.25	-0.28	-0.14	Upgrade
Quick Ratio	11.56	0.07	6.49	9.61	6.56	29.02	Upgrade
Current Ratio	11.98	0.11	6.61	9.99	6.69	29.39	Upgrade
Return on Equity (ROE)	-5693.84%	-123.51%	-102.98%	-75.25%	-58.77%	-29.40%	Upgrade
Return on Assets (ROA)	-143.66%	-66.45%	-85.51%	-60.84%	-51.36%	-27.95%	Upgrade
Return on Capital (ROIC)	-553.54%	-334.01%	-713.68%	-408.45%	-604.10%	-496.46%	Upgrade
Return on Capital Employed (ROCE)	-213.40%	-90.96%	-96.30%	-68.28%	-55.93%	-29.17%	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q